Press Release CNS Pharmaceuticals Participates in the Virtual Investor “Why Now” On-Demand Conference 4 hours ago
Press Release CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation Aug 12